Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00773097
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma
Condition: Risk for Colorectal Cancer
Intervention: Biological: MUC1 - Poly ICLC

Indicates status has not been verified in more than two years